|
1
|
Agarwala SS: Current systemic therapy for
metastatic melanoma. Expert Rev Anticancer Ther. 9:587–595. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller AJ and Mihm MC Jr: Melanoma. N Engl
J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blake CJ: Analytical procedures for
water-soluble vitamins in foods and dietary supplements: A review.
Anal Bioanal Chem. 389:63–76. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McCormick WJ: Cancer: A collagen disease,
secondary to a nutritional deficiency. Arch Pediatr. 76:166–171.
1959.PubMed/NCBI
|
|
5
|
Yun J, Mullarky E, Lu C, Bosch KN,
Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, et
al: Vitamin C selectively kills KRAS and BRAF mutant colorectal
cancer cells by targeting GAPDH. Science. 350:1391–1396. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Q, Espey MG, Krishna MC, Mitchell JB,
Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic
ascorbic acid concentrations selectively kill cancer cells: Action
as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl
Acad Sci USA. 102:13604–13609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Q, Espey MG, Sun AY, Lee JH, Krishna
MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR and Levine
M: Ascorbate in pharmacologic concentrations selectively generates
ascorbate radical and hydrogen peroxide in extracellular fluid in
vivo. Proc Natl Acad Sci USA. 104:8749–8754. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Q, Espey MG, Sun AY, Pooput C, Kirk
KL, Krishna MC, Khosh DB, Drisko J and Levine M: Pharmacologic
doses of ascorbate act as a prooxidant and decrease growth of
aggressive tumor xenografts in mice. Proc Natl Acad Sci USA.
105:11105–11109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takemura Y, Satoh M, Satoh K, Hamada H,
Sekido Y and Kubota S: High dose of ascorbic acid induces cell
death in mesothelioma cells. Biochem Biophys Res Commun.
394:249–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du J, Martin SM, Levine M, Wagner BA,
Buettner GR, Wang SH, Taghiyev AF, Du C, Knudson CM and Cullen JJ:
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer.
Clin Cancer Res. 16:509–520. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jia L, Jia Q, Shang Y, Dong X and Li L:
Vitamin C intake and risk of renal cell carcinoma: A meta-analysis.
Sci Rep. 5:179212015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian W, Wang Y, Xu Y, Guo X, Wang B, Sun
L, Liu L, Cui F, Zhuang Q, Bao X, et al: The hypoxia-inducible
factor renders cancer cells more sensitive to vitamin C-induced
toxicity. J Biol Chem. 289:3339–3351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Burke PJ: Mitochondria, bioenergetics and
apoptosis in cancer. Trends Cancer. 3:857–870. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee KE, Hahm E, Bae S, Kang JS and Lee WJ:
The enhanced tumor inhibitory effects of gefitinib and L-ascorbic
acid combination therapy in non-small cell lung cancer cells. Oncol
Lett. 14:276–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
De Francesco EM, Bonuccelli G, Maggiolini
M, Sotgia F and Lisanti MP: Vitamin C and Doxycycline: A synthetic
lethal combination therapy targeting metabolic flexibility in
cancer stem cells (CSCs). Oncotarget. 8:67269–67286. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frommel TO and Zarling EJ: Chronic
inflammation and cancer: Potential role of Bcl-2 gene family
members as regulators of cellular antioxidant status. Med
Hypotheses. 52:27–30. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Volkmann N, Marassi FM, Newmeyer DD and
Hanein D: The rheostat in the membrane: BCL-2 family proteins and
apoptosis. Cell Death Differ. 21:206–215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Raisova M, Hossini AM, Eberle J, Riebeling
C, Wieder T, Sturm I, Daniel PT, Orfanos CE and Geilen CC: The
Bax/Bcl-2 ratio determines the susceptibility of human melanoma
cells to CD95/Fas-mediated apoptosis. J Invest Dermatol.
117:333–340. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Antonsson B, Montessuit S, Sanchez B and
Martinou JC: Bax is present as a high molecular weight
oligomer/complex in the mitochondrial membrane of apoptotic cells.
J Biol Chem. 276:11615–11623. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coulter ID, Hardy ML, Morton SC, Hilton
LG, Tu W, Valentine D and Shekelle PG: Antioxidants vitamin C and
vitamin e for the prevention and treatment of cancer. J Gen Intern
Med. 21:735–744. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mata AM, Carvalho RM, Alencar MV,
Cavalcante AA and Silva BB: Ascorbic acid in the prevention and
treatment of cancer. Rev Assoc Med Bras (1992). 62:680–686. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Frei B and Lawson S: Vitamin C and cancer
revisited. Proc Natl Acad Sci USA. 105:11037–11038. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Padayatty SJ, Sun H, Wang Y, Riordan HD,
Hewitt SM, Katz A, Wesley RA and Levine M: Vitamin C
pharmacokinetics: Implications for oral and intravenous use. Ann
Intern Med. 140:533–537. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Monti DA, Mitchell E, Bazzan AJ, Littman
S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S and Levine
M: Phase I evaluation of intravenous ascorbic acid in combination
with gemcitabine and erlotinib in patients with metastatic
pancreatic cancer. PLoS One. 7:e297942012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Subbarayan PR, Lima M and Ardalan B:
Arsenic trioxide/ascorbic acid therapy in patients with refractory
metastatic colorectal carcinoma: A clinical experience. Acta Oncol.
46:557–561. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bael TE, Peterson BL and Gollob JA: Phase
II trial of arsenic trioxide and ascorbic acid with temozolomide in
patients with metastatic melanoma with or without central nervous
system metastases. Melanoma Res. 18:147–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Welch JS, Klco JM, Gao F, Procknow E, Uy
GL, Stockerl-Goldstein KE, Abboud CN, Westervelt P, DiPersio JF,
Hassan A, et al: Combination decitabine, arsenic trioxide, and
ascorbic acid for the treatment of myelodysplastic syndrome and
acute myeloid leukemia: A phase I study. Am J Hematol. 86:796–800.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carr A and Frei B: Does vitamin C act as a
pro-oxidant under physiological conditions? FASEB J. 13:1007–1024.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang G, Yan Y, Ma Y and Yang Y: Vitamin C
at high concentrations induces cytotoxicity in malignant melanoma
but promotes tumor growth at low concentrations. Mol Carcinog.
56:1965–1976. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
McCarty MF and Contreras F: Increasing
superoxide production and the labile iron pool in tumor cells may
sensitize them to extracellular ascorbate. Front Oncol. 4:2492014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ohwada R, Ozeki Y and Saitoh Y: High-dose
ascorbic acid induces carcinostatic effects through hydrogen
peroxide and superoxide anion radical generation-induced cell death
and growth arrest in human tongue carcinoma cells. Free Radic Res.
51:684–692. 2017.PubMed/NCBI
|
|
33
|
Perez-Cruz I, Cárcamo JM and Golde DW:
Caspase-8 dependent TRAIL-induced apoptosis in cancer cell lines is
inhibited by vitamin C and catalase. Apoptosis. 12:225–234. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hong SW, Jin DH, Hahm ES, Yim SH, Lim JS,
Kim KI, Yang Y, Lee SS, Kang JS, Lee WJ, et al: Ascorbate (vitamin
C) induces cell death through the apoptosis-inducing factor in
human breast cancer cells. Oncol Rep. 18:811–815. 2007.PubMed/NCBI
|
|
35
|
Zou W, Yue P, Lin N, He M, Zhou Z, Lonial
S, Khuri FR, Wang B and Sun SY: Vitamin C inactivates the
proteasome inhibitor PS-341 in human cancer cells. Clin Cancer Res.
12:273–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reddy VG, Khanna N and Singh N: Vitamin C
augments chemotherapeutic response of cervical carcinoma HeLa cells
by stabilizing P53. Biochem Biophys Res Commun. 282:409–415. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
An SH, Kang JH, Kim DH and Lee MS: Vitamin
C increases the apoptosis via up-regulation p53 during cisplatin
treatment in human colon cancer cells. BMB Rep. 44:211–216. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nagappan A, Park KI, Park HS, Kim JA, Hong
GE, Kang SR, Lee DH, Kim EH, Lee WS, Won CK and Kim GS: Vitamin C
induces apoptosis in AGS cells by down-regulation of 14-3-3σ via a
mitochondrial dependent pathway. Food Chem. 135:1920–1928. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aumailley L, Warren A, Garand C, Dubois
MJ, Paquet ER, Le Couteur DG, Marette A, Cogger VC and Lebel M:
Vitamin C modulates the metabolic and cytokine profiles, alleviates
hepatic endoplasmic reticulum stress, and increases the life span
of Gulo-/-mice. Aging (Albany NY). 8:458–483. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lim JY, Kim D, Kim BR, Jun JS, Yeom JS,
Park JS, Seo JH, Park CH, Woo HO, Youn HS, et al: Vitamin C induces
apoptosis in AGS cells via production of ROS of mitochondria. Oncol
Lett. 12:4270–4276. 2016. View Article : Google Scholar : PubMed/NCBI
|
